SEVERITY & EXTENT OF MYOCARDIAL INFARCTION IN DIABETIC PATIENT TAKING INSULIN & SULFONYLUREAS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

PEZESHKI A.; TALEBIPOUR B.; KHANI M.; MOUSAVINASAB S.N.A.D.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Advances in Medical and Biomedical Research Year:2000 | Volume:8 | Issue:30-31 Page(s): 49-53

Download Full-Text

Persian Verion

View:

723

Download:

Cites:

Information Journal Paper

Title

SEVERITY & EXTENT OF MYOCARDIAL INFARCTION IN DIABETIC PATIENT TAKING INSULIN & SULFONYLUREAS

Author(s)

PEZESHKI A. | TALEBIPOUR B. | KHANI M. | MOUSAVINASAB S.N.A.D. | Issue Writer Certificate

Keywords

Not Registered.

Abstract

In previous studies it was thought that the prevalence, Extent & severity of MI iin diabetic P. taking sulfonylureas were much more than diabelic. P. Taking Insulin.Outcomes of some studies were conflicting so FDA ordered to consider some extra risk which pointed in the brochures of these drugs. In this study type Hypotesis were increased severity & extent of MI in diabetic. p. Taking sulfonylurea.A prospective study (clinical trial) in 2 years were done on the following patient: patient with MI who were admitted in CCU with no history of Heart disease. 26 People who were receiving Insulin and 46 people who were receiving sulfonylurea. Compared with 86 non diabetic people as a control group.Severity of MI is evaluated with Ejection fraction (EF) ant Extent of MI is evaluated with area under curve of CPK with at least of 6 samples CPK. Confounding factor such as age - sex - History of Hypertension. Hyperlipidemia, Smoking, type of MI and arrhythmia were considered.Therefore confounding factor were the same in both Diabetic groups. There was not any significant difference in EF and area under CPK curve.Use of sulfonylurea drugs for D.M don't increase extent and severity of MI, but its effect of increasing prevalence of MI should be studied.

Cites

بررسی کاندیدوریا در بیماران دیابتی شهر زنجان در سال 1380

References

No record.

Cite

APA: Copy

PEZESHKI, A., TALEBIPOUR, B., KHANI, M., & MOUSAVINASAB, S.N.A.D.. (2000). SEVERITY & EXTENT OF MYOCARDIAL INFARCTION IN DIABETIC PATIENT TAKING INSULIN & SULFONYLUREAS. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, 8(30-31), 49-53. SID. https://sid.ir/paper/61459/en

Vancouver: Copy

PEZESHKI A., TALEBIPOUR B., KHANI M., MOUSAVINASAB S.N.A.D.. SEVERITY & EXTENT OF MYOCARDIAL INFARCTION IN DIABETIC PATIENT TAKING INSULIN & SULFONYLUREAS. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH[Internet]. 2000;8(30-31):49-53. Available from: https://sid.ir/paper/61459/en

IEEE: Copy

A. PEZESHKI, B. TALEBIPOUR, M. KHANI, and S.N.A.D. MOUSAVINASAB, “SEVERITY & EXTENT OF MYOCARDIAL INFARCTION IN DIABETIC PATIENT TAKING INSULIN & SULFONYLUREAS,” JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, vol. 8, no. 30-31, pp. 49–53, 2000, [Online]. Available: https://sid.ir/paper/61459/en

Related Journal Papers